⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

IMCD IMCD.AS

Netherlands Basic Materials
5.6/10
AI Analyst score
95.64 EUR
Last price at analysis date · analyst target 117.36 (+22.7%)
🛒 Where to buy IMCD.ASPartner brokers · Netherlands (Euronext) · sample 200.00 € orderNetherlands (Euronext)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold; business quality and moderate growth offset leverage, but rising rates limit upside potential.

IMCD is a global distributor of specialty chemicals and ingredients, acting as an intermediary between manufacturers and end customers, offering value-added services such as formulation, logistics and technical support. IMCD shows moderate financial health (5.33) with high debt (ND/EBITDA 3.02) but acceptable business quality (ROIC 11.08%) and reasonable valuation (PER 24.59, FCF yield 4.73%). Revenue growth of 6.6% and positive momentum (8.33% over 12 months) suggest stability, although leverage and the high-rate environment are the main risks.

Financial health
5.0
Quality / Moat
5.1
Valuation
5.8
Growth
6.1
Dividend
6.7
Momentum
4.4
Risk & Context
6.2

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E24.59
Fwd P/E14.65
EV/EBITDA14.00
P/B2.66
P/S1.14
PEG1.46
Market cap5.65 B EUR
Enterprise value7.22 B EUR
🏰 Quality and moat
ROIC (approx.)11.1%
Gross margin25.01%
FCF conversion52%
Operating margin8.76%
📈 Profitability and margins
ROE11.22%
ROA5.24%
Net margin4.63%
FCF266.9 M EUR
FCF yield4.73%
🏦 Solvency and liquidity
Total debt1.81 B EUR
Net debt1.56 B EUR
Cash248.7 M EUR
EBITDA515.9 M EUR
Net debt / EBITDA3.02
D/E85.12
Current ratio1.35
Quick ratio0.85
🚀 Growth
Revenue growth6.60%
Earnings growth10.00%
EPS (TTM)3.89 EUR
EPS (Fwd)6.47 EUR
💰 Dividend and risk
Dividend yield1.89%
Payout46.5%
Beta0.97
Analyst consensusBuy (14)
Target price117.36 EUR
52-week range68.14 EUR – 105.05 EUR
⚠️ Main risk: High leverage (ND/EBITDA 3.02) in a rising-rate environment (ECB hiking) could compress financial margins and limit investment capacity.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

IMCD is a global distributor of specialty chemicals and ingredients, acting as an intermediary between manufacturers and end customers, offering value-added services such as formulation, logistics and technical support. IMCD shows moderate financial health (5.33) with high debt (ND/EBITDA 3.02) but acceptable business quality (ROIC 11.08%) and reasonable valuation (PER 24.59, FCF yield 4.73%). Revenue growth of 6.6% and positive momentum (8.33% over 12 months) suggest stability, although leverage and the high-rate environment are the main risks.

Score by category

CategoryScore
Financial health5.0
Quality / Moat5.1
Valuation5.8
Growth6.1
Dividend6.7
Momentum4.4
Risk & Context6.2

OVERALL SCORE: 5.6/10

Context and risks

The oil rally and 10-year yield at 5.17% increase financing costs for the chemical supply chain, but IMCD is a distributor with stable margins and low direct interest rate risk. Geopolitical exposure is limited; the main risk is the European industrial slowdown affecting demand for specialty chemicals.

News considered in the analysis

  • IMCD NV (IMCDY) (H1 2026) Earnings Call Highlights: Strong Cash Flow and EMEA Growth Offset by ... — Resultados semestrales con flujo de caja fuerte y crecimiento en EMEA, aunque con cierta debilidad en otras regiones; refuerza la tesis de calidad operativa.
  • Favourable Signals For IMCD: Numerous Insiders Acquired Stock — Las compras de consejeros y directivos son una señal positiva de confianza interna en el valor.
  • Is IMCD (ENXTAM:IMCD) Pricing Reflect Its Sharp 1-Year Share Price Slide? — Artículo especulativo sobre la valoración tras la caída de la acción; sin información nueva concreta.
  • IMCD NV (IMCDY) Full Year 2025 Earnings Call Highlights: Strategic Acquisitions and Cash Flow ... — La estrategia de adquisiciones y la generación de caja son positivas para el crecimiento a largo plazo.
  • IMCD's (AMS:IMCD) earnings trajectory could turn positive as the stock climbs 8.8% this past week — Comentario sobre la evolución reciente del precio; sin impacto fundamental nuevo.

Verdict: Hold; business quality and moderate growth offset leverage, but rising rates limit upside potential.

Main risk: High leverage (ND/EBITDA 3.02) in a rising-rate environment (ECB hiking) could compress financial margins and limit investment capacity.

Other Basic Materials companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.